絞り込み

16642

広告

L-3-n-butylphthalide soft capsules in the treatment of Parkinson disease dementia: A systematic review and meta-analysis of randomized controlled trials.

著者 Zhong R , Chen Q , Zhang X , Li M , Lin W
Medicine (Baltimore).2019 Jun ; 98(24):e16082.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (12view , 1users)

Full Text Sources

Medical

In recent years, L-3-n-butylphthalide (L-NBP) has been used for Parkinson disease dementia (PDD) to attenuate cognitive impairments in China. Therefore, we selected published and qualified clinical trials to conduct a systematic review and meta-analysis with the aim of assessing the effectiveness and safety of L-NBP in the treatment of PDD.
PMID: 31192971 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード